Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jul 23, 2021
Date Accepted: Sep 14, 2021
Date Submitted to PubMed: Sep 20, 2021

The final, peer-reviewed published version of this preprint can be found here:

Ethics, Integrity, and Retributions of Digital Detection Surveillance Systems for Infectious Diseases: Systematic Literature Review

Zhao YI, Ma YX, Yu MWC, Liu J, Dong WN, Pang Q, Lu XQ, Molassiotis A, Holroyd E, Wong CWW

Ethics, Integrity, and Retributions of Digital Detection Surveillance Systems for Infectious Diseases: Systematic Literature Review

J Med Internet Res 2021;23(10):e32328

DOI: 10.2196/32328

PMID: 34543228

PMCID: 8530254

Ethics, Integrity and Retributions of Digital Detection Surveillance Systems on Infectious Diseases: Systematic literature review

  • Yan Ivy Zhao; 
  • Ye Xuan Ma; 
  • Man Wai Cecilia Yu; 
  • Jia Liu; 
  • Wei Nan Dong; 
  • Qin Pang; 
  • Xiao Qin Lu; 
  • Alex Molassiotis; 
  • Eleanor Holroyd; 
  • Chi Wai William Wong

ABSTRACT

Background:

The COVID-19 pandemic has raised the importance of the deployment of digital detection surveillance systems to support early warning and monitoring of infectious diseases (ID). These opportunities create a “double-edge sword” as the ethical governance of such approaches often lag behind technological achievements.

Objective:

The aim was to explore the intersection of individuals’ autonomy and healthcare rights with those of common good for population-based public health outcomes specific to ID control and prevention.

Methods:

We searched relevant articles in a number of databases that addressed ethical issues of using artificial intelligence, digital surveillance systems, early warning systems and/or big data analytics technology for detecting, monitoring, or tracing ID according to PRISMA guidelines, and further identified and analysed them with a theoretical framework.

Results:

This systematic review identified 29 articles presented in six major themes clustered under individual, organisational and societal levels, including: awareness of implementing digital surveillance, digital integrity, trust, privacy and confidentiality, civil rights, and governance. Whilst these measures were understandable during a pandemic, the public were concerned about receiving inadequate information, unclear governance frameworks, and lack of privacy protection, data integrity and autonomy when utilizing ID digital surveillance. The barriers to engagement could widen existing healthcare disparities or digital divides by underrepresenting vulnerable and at-risk populations, and expose patients’ highly sensitive data such as their movements and contacts to outside sources, impinging significantly upon basic human and civil rights.

Conclusions:

Our findings inform ethical considerations for service delivery models for medical practitioners and policymakers implicated in the use of digital surveillance for ID spread and a basis for the global governance structure.


 Citation

Please cite as:

Zhao YI, Ma YX, Yu MWC, Liu J, Dong WN, Pang Q, Lu XQ, Molassiotis A, Holroyd E, Wong CWW

Ethics, Integrity, and Retributions of Digital Detection Surveillance Systems for Infectious Diseases: Systematic Literature Review

J Med Internet Res 2021;23(10):e32328

DOI: 10.2196/32328

PMID: 34543228

PMCID: 8530254

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.